Michael Kenison

Corporate Officer/Principal bei PROTO LABS, INC.

Vermögen: 692 210 $ am 31.05.2024

Process Industries

Commercial Services

Aktive Positionen von Michael Kenison

Unternehmen	Position	Beginn	Ende
PROTO LABS, INC.	Corporate Officer/Principal	01.06.2021	-

Unternehmen	Position	Beginn	Ende
Cardiac Science, Inc. Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide.	Corporate Officer/Principal	-	-

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal

Sektoral

Process Industries	2
Commercial Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
PROTO LABS, INC.	Process Industries

Private Unternehmen	1
Cardiac Science, Inc. Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide.	Commercial Services

Private Unternehmen

Commercial Services